Middle East & Africa Eye Drops Market Forecast to 2030 - Regional Analysis - by Type, Application {Eye Diseases, Eye Care, and Others}, and Purchase Mode

The Middle East & Africa eye drops market is expected to grow from US$ 424.84 million in 2022 to US$ 580.44 million by 2030. It is estimated to grow at a CAGR of 4.0% from 2022 to 2030.

Changing Lifestyle Fuels Middle East & Africa Eye Drops Market

Eye diseases hold a substantial share in lifestyle diseases due to the increased use of smartphones, laptops, and computers. The modern lifestyle, which involves increased screen time, is responsible for triggering eye-related problems. Eye health is significantly compromised in this technological era. Working on computers for a long time eventually affects the health of the eyes. Individuals with chronic eye problems and refractive errors are at higher risk of developing digital eye strain (DES).

Extreme exposure to blue rays emitting from smartphones, tablets, iPads, and laptops also causes serious eye damage. Due to the COVID-19 outbreak, all companies opted for work-from-home (WFH) to prevent the spread of COVID-19. The growing trend of WFH has intensified the screen time of working professionals, further accelerating the number of eye-related issues. According to a study published by the Springer, during the COVID-19 lockdown, increase in longer time usage of digital devices, population in Saudi Arabia complained about increase eye strain. According to a study published by Frontiers, the repeated use of digital devices for more than two continuous hours is putting the user at a great risk of developing DES due to the excessive accommodative demands. Although the spread of COVID-19 has been controlled to a large extent, many companies have allowed their employees to continue with WFH to decrease the overall expenditure. This flexibility with regard to work location has led to an increase in screen time. Such lifestyle changes will eventually damage eye health, generating a greater demand for eye drops.

Middle East & Africa Eye Drops Market Overview

The Middle East & Africa eye drops market t is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Increase in prevalence of eye diseases in geriatric population of the region and increase in cases of dry eye diseases and cataract in countries such as Saudi Arabia, and UAE is fueling the growth of Middle East & Africa eye drops market in Middle East & Africa. The majority of dry eye conditions are associated with diabetes. The incidence of diabetes is increasing significantly in South Africa. According to the International Diabetes Federation, as of April 2020, 19 million people were living with diabetes in the country, and the number is estimated to reach 47 million by 2045. Such a high incidence would result in an increased risk of dry eye among diabetic people. Diversified climatic conditions with extreme temperature is another prime factor contributing to the growing incidence of dry eye condition. According to Statistics South Africa (Stats SA) estimates, the population of South Africa was ~59.62 million by mid-2020 and roughly 5.43 million people are aged 60 and above. The association of dry eye with old age is an influential factor boosting the adoption of eye drops in South Africa.

Middle East & Africa Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Eye Drops Market Segmentation

The Middle East & Africa eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the Middle East & Africa eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the Middle East & Africa eye drops market in 2022.

Based on application, the Middle East & Africa eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the Middle East & Africa eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the Middle East & Africa eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the Middle East & Africa eye drops market in 2022.

Based on country, the Middle East & Africa eye drops market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa eye drops market in 2022.

AbbVie Inc, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, and Rohto Pharmaceutical Co Ltd are some of the leading companies operating in the Middle East & Africa eye drops market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Eye Drops Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.